Pierre Gantner
Overview
Explore the profile of Pierre Gantner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1749
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Deng X, Gantner P, Forestell J, Pagliuzza A, Brunet-Ratnasingham E, Durand M, et al.
Clin Transl Immunology
. 2023 Nov;
12(11):e1468.
PMID: 38020729
Objectives: Identifying biomarkers causing differential SARS-CoV-2 infection kinetics associated with severe COVID-19 is fundamental for effective diagnostics and therapeutic planning. Methods: In this work, we applied mathematical modelling to investigate...
12.
Faua C, Fafi-Kremer S, Gantner P
J Virus Erad
. 2023 Jul;
9(2):100329.
PMID: 37440870
Antigen-experienced memory CD4 T cells are the major target of HIV infection and support both productive and latent infections, thus playing a key role in HIV dissemination and persistence, respectively....
13.
Gantner P, Buranapraditkun S, Pagliuzza A, Dufour C, Pardons M, Mitchell J, et al.
Immunity
. 2023 Feb;
56(3):653-668.e5.
PMID: 36804957
Upon infection, HIV disseminates throughout the human body within 1-2 weeks. However, its early cellular targets remain poorly characterized. We used a single-cell approach to retrieve the phenotype and TCR...
14.
Gallais F, Gantner P, Planas D, Solis M, Bruel T, Pierre F, et al.
Front Immunol
. 2022 Mar;
13:790212.
PMID: 35281046
Background: SARS-CoV-2 breakthrough infections after complete vaccination are increasing whereas their determinants remain uncharacterized. Methods: We analyzed two cases of post-vaccination SARS-CoV-2 infections by α and β variants, respectively. For...
15.
Brunet-Ratnasingham E, Anand S, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, et al.
Sci Adv
. 2021 Nov;
7(48):eabj5629.
PMID: 34826237
Despite advances in COVID-19 management, identifying patients evolving toward death remains challenging. To identify early predictors of mortality within 60 days of symptom onset (DSO), we performed immunovirological assessments on...
16.
Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling M, et al.
EBioMedicine
. 2021 Aug;
71:103561.
PMID: 34455390
Background: Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting risk of reinfection and durability of vaccine protection. Methods: This is a prospective, monocentric, longitudinal, cohort clinical study....
17.
Benotmane I, Gautier-Vargas G, Gallais F, Gantner P, Cognard N, Olagne J, et al.
Am J Transplant
. 2021 Jul;
21(11):3808-3810.
PMID: 34254431
No abstract available.
18.
Martinot M, Carnein S, Kempf C, Gantner P, Gallais F, Fafi-Kremer S
Clin Microbiol Infect
. 2021 Jul;
27(10):1537-1539.
PMID: 34242805
No abstract available.
19.
Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah M, et al.
Nature
. 2021 Jul;
596(7871):276-280.
PMID: 34237773
The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India. Since then, it has become dominant in some regions of India and in the UK, and has spread to...
20.
Cole B, Lambrechts L, Gantner P, Noppe Y, Bonine N, Witkowski W, et al.
Nat Commun
. 2021 Jun;
12(1):3727.
PMID: 34140517
Clonal expansion of HIV-infected cells contributes to the long-term persistence of the HIV reservoir in ART-suppressed individuals. However, the contribution from cell clones that harbor inducible proviruses to plasma viremia...